Related Experiment Video
Updated: Jun 23, 2025
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.8K
Comorbid Insomnia and Sleep Apnea: COMISA
1Unidade de Sono, Centro Cardiovascular da Universidade, de Lisboa (CCUL@RISE), Faculdade de Medicina da, Universidade de Lisboa, Av. Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Dental Clinics of North America
|June 15, 2024
Summary
Comorbid insomnia and sleep apnea (COMISA) links stress and heart risks. Understanding this connection is key for new treatments, like mandibular devices, to manage these common sleep disorders.
Area of Science:
- Sleep Medicine
- Cardiology
- Internal Medicine
Background:
- Comorbid insomnia and sleep apnea (COMISA) represents a convergence of prevalent sleep disorders.
- Both insomnia and sleep apnea are independently linked to elevated stress and cardiometabolic risk.
- Understanding COMISA is crucial for elucidating underlying pathophysiological pathways.
Purpose of the Study:
- To provide a comprehensive overview of the epidemiologic aspects of COMISA.
- To review clinical findings associated with COMISA.
- To explore the mechanisms underlying COMISA and discuss therapeutic strategies.
Main Methods:
- Literature review and synthesis of existing research on COMISA.
- Epidemiological data analysis.
- Clinical case study review.
Main Results:
- COMISA is associated with significant increases in stress levels and cardiometabolic risk factors.
- Specific pathophysiological mechanisms linking insomnia and sleep apnea are being identified.
- Odontostomatological approaches, particularly mandibular advancement devices, show promise.
Conclusions:
- COMISA presents a significant health burden due to its association with stress and cardiometabolic disease.
- Further research into COMISA mechanisms is needed to refine therapeutic interventions.
- Mandibular advancement devices offer a viable treatment option for managing COMISA.
Keywords:
COMISACardiometabolic riskComorbid insomniaComorbid sleep apneaComorbid sleep disordered breathingMandibular advancement devicesStressMore Related Videos
Related Concept Videos
01:21Sleep Apnea
143
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
143
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:27Insomnia
82
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
82
01:24Substance Use Disorders Affecting Sleep
164
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
164
01:17Sleepwalking and Sleep Talking
142
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
142
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168